RNU6-1211P

Across TCGA pan-cancer cohorts, RNU6-1211P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU6-1211P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-1211P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1211P expression acts as an unfavorable survival marker.

STAD, LIHC, and KIRC are the cancer types where RNU6-1211P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	IV	0.111	0.492	.001	108	view →
LIHC	OS	Tertile	All	0.118	0.783	<.001	45	view →
KIRC	DFS	Tertile	II,III,IV	0.139	0.503	.030	42	view →
SKCM	DFS	Tertile	All	0.209	0.728	.020	18	view →
LGG	DFS	Tertile	All	0.156	0.753	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU6-1211P–STAD (DFS)

Open the STAD breakdown →